Summit Trail Advisors LLC Purchases New Stake in Teladoc Health, Inc. (NYSE:TDOC)

Summit Trail Advisors LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOCFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 10,159 shares of the health services provider’s stock, valued at approximately $92,000.

Other hedge funds have also added to or reduced their stakes in the company. Versant Capital Management Inc boosted its holdings in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares during the last quarter. Blue Trust Inc. boosted its holdings in Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after buying an additional 1,854 shares during the last quarter. Signaturefd LLC boosted its holdings in Teladoc Health by 162.7% during the third quarter. Signaturefd LLC now owns 7,535 shares of the health services provider’s stock worth $69,000 after buying an additional 4,667 shares during the last quarter. KBC Group NV boosted its holdings in Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock worth $80,000 after buying an additional 3,714 shares during the last quarter. Finally, Westside Investment Management Inc. boosted its holdings in Teladoc Health by 43.8% during the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after buying an additional 2,800 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of recent analyst reports. Piper Sandler restated an “overweight” rating and set a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. The Goldman Sachs Group assumed coverage on Teladoc Health in a report on Friday, November 15th. They set a “buy” rating and a $14.00 target price on the stock. TD Cowen dropped their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Royal Bank of Canada raised their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Oppenheimer dropped their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Fourteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $12.08.

View Our Latest Research Report on Teladoc Health

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.95% of the stock is owned by insiders.

Teladoc Health Stock Up 7.6 %

Shares of Teladoc Health stock opened at $13.51 on Friday. The business’s 50 day simple moving average is $10.22 and its 200 day simple moving average is $9.25. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $21.74. The firm has a market cap of $2.33 billion, a PE ratio of -2.34 and a beta of 1.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Articles

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCFree Report).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.